However, phase 2 trials are not powered to detect rare cardiovascular events
Final eligibility will depend on FDA labeling and clinical guidelines
This information helps your healthcare provider assess patterns and determine whether investigation is needed
Crucially, the $50 monthly copay for GLP-1s will not count toward a patient's Part D deductible, or the $2,100 annual out-of-pocket cap on prescription drug costs, said Rachel Schmidt, a research professor at Georgetown University's McCourt School of Public Policy
Moreover, due to its potent effect on gastrointestinal function, it can lead to delayed gastric emptying and alter intestinal motility
Regular liver function tests are essential, especially for long-term research